• 1. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 2. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 3. Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations
  Benjamin Gabriel Poulson,Kacper Szczepski,Joanna Izabela Lachowicz,Lukasz Jaremko,Abdul-Hamid Emwas,Mariusz Jaremko RSC Adv., 2020,10, 215-227
• 4. An assay for the enzyme N-acetyl-β-d-glucosaminidase (NAGase) based on electrochemical detection using screen-printed carbon electrodes (SPCEs)
  R. M. Pemberton,J. P. Hart,T. T. Mottram Analyst, 2001,126, 1866-1871
• 5. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Methyl (S)-azetidine-2-carboxylate: A Comprehensive Overview

Methyl (S)-azetidine-2-carboxylate, with the CAS number 69684-70-4, is a compound of significant interest in the fields of organic chemistry and pharmaceutical research. This compound, also known as methyl (S)-azetidine-2-carboxylate, is a derivative of azetidine, a four-membered cyclic amine. The S configuration denotes the stereochemistry at the chiral center, which is critical for its biological activity and applications.

The synthesis of methyl (S)-azetidine-2-carboxylate involves a series of well-established organic reactions, including alkylation, oxidation, and stereocontrol techniques. Recent advancements in asymmetric synthesis have enabled the efficient production of this compound with high enantiomeric excess, making it a valuable intermediate in drug discovery programs. Its structure is characterized by a four-membered azetidine ring fused to a carboxylic acid group, which can be further modified to explore its pharmacological potential.

One of the most promising applications of methyl (S)-azetidine-2-carboxylate lies in its use as a building block for complex molecules. Researchers have employed this compound in the construction of bioactive compounds, such as kinase inhibitors and GPCR modulators. For instance, studies published in *Nature Communications* and *Journal of Medicinal Chemistry* highlight its role in designing novel therapeutic agents targeting cancer and neurodegenerative diseases.

Moreover, the stereochemical integrity of methyl (S)-azetidine-2-carboxylate plays a pivotal role in its interactions with biological systems. Computational studies using molecular docking and dynamics simulations have revealed that this compound exhibits favorable binding affinities to various protein targets. These findings underscore its potential as a lead compound for drug development.

In terms of physical properties, methyl (S)-azetidine-2-carboxylate is typically obtained as a white crystalline solid with a melting point around 150°C. Its solubility in common organic solvents such as dichloromethane and ethyl acetate makes it amenable to various synthetic transformations. The compound's stability under standard storage conditions further enhances its utility in research settings.

Recent research has also focused on the green chemistry aspects of synthesizing methyl (S)-azetidine-2-carboxylate. Investigators have explored catalytic asymmetric methods that minimize waste and improve atom economy. For example, the use of enzyme-catalyzed reactions or organocatalysts has emerged as an environmentally friendly approach to producing this compound on an industrial scale.

Looking ahead, the versatility of methyl (S)-azetidine-2-carboxylate positions it as a key player in advancing drug discovery pipelines. Its ability to serve as both a structural motif and a functional group-modifiable entity opens up new avenues for exploring chemical space. Collaborative efforts between academic institutions and pharmaceutical companies are expected to drive further innovation in this area.

In conclusion, methyl (S)-azetidine-2-carboxylate is more than just a chemical entity; it represents a bridge between synthetic chemistry and therapeutic innovation. With ongoing research uncovering new applications and improved synthesis routes, this compound continues to be at the forefront of scientific exploration.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)